Orchestra BioMed Holdings (OBIO) Non Operating Income (2023 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Non Operating Income came in at -$821000.0 in Q1 2026, down 594.58% year-on-year from $166000.0 in Q1 2025, and down 7.6% on a QoQ basis from -$763000.0 in Q4 2025.
Orchestra BioMed Holdings (OBIO) Non Operating Income (2023 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 4 years of Non Operating Income data on file, last reported at -$821000.0 in Q1 2026.
- On a quarterly basis, Non Operating Income fell 594.58% year-over-year to -$821000.0 in Q1 2026; TTM through Mar 2026 was -$2.1 million, a 185.2% decrease from a year earlier, with the FY2025 full-year figure at -$1.1 million, down 134.21% from the prior year.
- Non Operating Income for Q1 2026 stood at -$821000.0, down from -$763000.0 in the prior quarter.
- Over the last five years, Non Operating Income for OBIO reached as high as $1.1 million in Q4 2023 and fell as low as -$821000.0 in Q1 2026.
- Historically, Non Operating Income has averaged $310000.0 across 4 years, with a median of $522000.0 in 2024.
- Across the five-year window, Non Operating Income grew 0.11% in 2024 and sank 594.58% in 2026, its largest moves.
- Year by year, Non Operating Income stood at $1.1 million in 2023, then slumped by 52.89% to $522000.0 in 2024, then tumbled by 246.17% to -$763000.0 in 2025, then decreased by 7.6% to -$821000.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were -$821000.0 in Q1 2026, -$763000.0 in Q4 2025, and -$515000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Orchestra BioMed Holdings | 235.83 Mn | 141.43 Mn | 78,000.00 | -821,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -821,000.00 |
| Dec 31, 2025 | -763,000.00 |
| Sep 30, 2025 | -515,000.00 |
| Jun 30, 2025 | -36,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Dec 31, 2024 | 522,000.00 |
| Sep 30, 2024 | 916,000.00 |
| Jun 30, 2024 | 902,000.00 |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 915,000.00 |